4//SEC Filing
Forman Mark S 4
Accession 0001209191-22-056613
CIK 0001787297other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 4:22 PM ET
Size
5.6 KB
Accession
0001209191-22-056613
Insider Transaction Report
Form 4
Forman Mark S
Chief Medical Officer
Transactions
- Award
Restricted Stock Unit
2022-11-10+50,000→ 50,000 total→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
- [F2]100% of the total RSUs will vest on December 31, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Documents
Issuer
Passage BIO, Inc.
CIK 0001787297
Entity typeother
Related Parties
1- filerCIK 0001922353
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 4:22 PM ET
- Size
- 5.6 KB